MaxLinear
MXLNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $53.83 Prior regular-session close from the quote source.
- $57.22–$63.23 Regular-session low and high so far today.
- 3.2M Regular-session shares traded · Nov 11, 4:00 PM ET.
- Not yet confirmed The company has not confirmed its next report date. Reported quarters are available in the chart’s Earnings view.
- $12.77–$128.30 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own MXL if its RF/mixed-signal SoC sockets recover without gross-margin erosion, but the stock fails if the 2022 revenue base was structurally lost rather than merely cycled down.
MXL price history
Loading recent earnings…
Investment thesis
What must happen next
Customer inventory digestion and end-market weakness are giving way to renewed shipment demand, and MaxLinear’s existing communications-chip design sockets are still converting into orders rather than being permanently displaced.HoldingMateriality: High
GAAP annual revenue increased to $467.6 million in FY2025 from $360.5 million in FY2024. If this holds, revenue recovery can validate the franchise; if it breaks, the business is structurally smaller than investors expect.
Watch: Broadcom, Qualcomm, MediaTek, or other communications-silicon suppliers win next-generation gateway, access, or connectivity platforms that MaxLinear previously served.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual revenue increased to $467.6 million in FY2025 from $360.5 million in FY2024.
Open source ↗MaxLinear’s RF/mixed-signal and communications SoC know-how remains differentiated enough that recovery does not require commodity-like price concessions.StrengtheningMateriality: High
GAAP gross profit rose to $265.8 million in FY2025 from $194.8 million in FY2024. Gross-margin durability determines whether incremental revenue becomes valuable profit or merely low-quality volume.
Watch: Broadcom or Marvell bundle competing communications chips with broader platform offerings and pressure MaxLinear pricing.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP gross profit rose to $265.8 million in FY2025 from $194.8 million in FY2024.
Open source ↗The fabless design model only creates equity value if MaxLinear can spread its engineering and product-development cost base over a larger sales base; that operating leverage has not yet been proven in the current cycle.WeakeningMateriality: Medium
GAAP annual operating loss improved to $126.9 million in FY2025 from a $223.4 million loss in FY2024. A revenue rebound without GAAP operating leverage would leave owners funding a technically capable but economically subscale design house.
Watch: Required R&D for new process nodes, communications standards, or customer-specific SoCs rises as fast as revenue, preventing operating leverage.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP annual operating loss improved to $126.9 million in FY2025 from a $223.4 million loss in FY2024.
Open source ↗The balance sheet can support a recovery only if the business continues moving toward self-funding; prolonged socket losses or renewed working-capital pressure would constrain strategic flexibility.HoldingMateriality: Medium
Cash was $72.8 million at FY2025 year-end. Cash runway affects MaxLinear’s ability to keep investing through the semiconductor cycle without distressed financing.
Watch: A prolonged customer demand pause forces MaxLinear to fund R&D and inventory from the balance sheet.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
Cash was $72.8 million at FY2025 year-end.
Open source ↗Per-share value creation depends on the recovery being funded by cash generation rather than equity issuance or balance-sheet repair, because operating losses have already pressured GAAP EPS.WeakeningMateriality: Medium
GAAP diluted EPS improved to a loss of $1.58 in FY2025 from a loss of $2.93 in FY2024. Even a real business recovery can disappoint shareholders if dilution or financing costs absorb the upside.
Watch: Management issues equity or equity-linked securities to fund operations, litigation, acquisitions, or product investment.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
GAAP diluted EPS improved to a loss of $1.58 in FY2025 from a loss of $2.93 in FY2024.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
Customer inventory digestion and end-market weakness are giving way to renewed shipment demand, and MaxLinear’s existing communications-chip design sockets are still converting into orders rather than being permanently displaced. If this holds, revenue recovery can validate the franchise; if it breaks, the business is structurally smaller than investors expect.
MaxLinear’s RF/mixed-signal and communications SoC know-how remains differentiated enough that recovery does not require commodity-like price concessions. Gross-margin durability determines whether incremental revenue becomes valuable profit or merely low-quality volume.
The fabless design model only creates equity value if MaxLinear can spread its engineering and product-development cost base over a larger sales base; that operating leverage has not yet been proven in the current cycle. A revenue rebound without GAAP operating leverage would leave owners funding a technically capable but economically subscale design house.
The balance sheet can support a recovery only if the business continues moving toward self-funding; prolonged socket losses or renewed working-capital pressure would constrain strategic flexibility. Cash runway affects MaxLinear’s ability to keep investing through the semiconductor cycle without distressed financing.
Per-share value creation depends on the recovery being funded by cash generation rather than equity issuance or balance-sheet repair, because operating losses have already pressured GAAP EPS. Even a real business recovery can disappoint shareholders if dilution or financing costs absorb the upside.
All standing thesis claims
Original report summary
its RF/mixed-signal SoC sockets recover without gross-margin erosion, but the stock fails if the 2022 revenue base was structurally lost rather than merely cycled down.
Bull case and bear case
Bull case and bear case for Maxlinear
Where the evidence on Maxlinear disagrees: Mixed on the latest evidence (Oct 13, 2026). Of its 5 thesis points, 1 strengthening, 2 holding and 2 weakening.
Bull case: what the evidence supports
Customer inventory digestion and end-market weakness are giving way to renewed shipment demand, and MaxLinear’s existing communications-chip design sockets are still converting into orders rather than being permanently displaced.
MaxLinear’s RF/mixed-signal and communications SoC know-how remains differentiated enough that recovery does not require commodity-like price concessions.
The balance sheet can support a recovery only if the business continues moving toward self-funding; prolonged socket losses or renewed working-capital pressure would constrain strategic flexibility.
Bear case: what the evidence questions
The fabless design model only creates equity value if MaxLinear can spread its engineering and product-development cost base over a larger sales base; that operating leverage has not yet been proven in the current cycle.
Per-share value creation depends on the recovery being funded by cash generation rather than equity issuance or balance-sheet repair, because operating losses have already pressured GAAP EPS.
Thesis-Break Engine
Thesis-break watch · Maxlinear
Loading the break-condition record for Maxlinear.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Maxlinear filed an SEC 8-K on 2026-07-23: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedChanged certifying accountant.
Maxlinear filed an SEC 8-K on 2026-06-01: Changed certifying accountant. It is a dated development that tests the current thesis.
- MixedDirector or principal officer change.
Maxlinear filed an SEC 8-K on 2026-05-21: Director or principal officer change. It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Broadcom, Qualcomm, MediaTek, or other communications-silicon suppliers win next-generation gateway, access, or connectivity platforms that MaxLinear previously served.
- Broadcom or Marvell bundle competing communications chips with broader platform offerings and pressure MaxLinear pricing.
- Required R&D for new process nodes, communications standards, or customer-specific SoCs rises as fast as revenue, preventing operating leverage.
- A prolonged customer demand pause forces MaxLinear to fund R&D and inventory from the balance sheet.
- Management issues equity or equity-linked securities to fund operations, litigation, acquisitions, or product investment.
MXL news
Loading headlines…
Financial statements
MXL income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
MXL: quick answers
- Which well-known investors own MXL?
- 2 of the 37 well-known funds tracked here reported MXL shares in their latest 13F filings. By share of the fund's portfolio: Maverick Capital, 0.0%; Bridgewater Associates (Ray Dalio), 0.0%. Fund portfolios
MXL in well-known investors’ portfolios
2 of 37 funds reported MXL shares in their latest 13F filing. A 13F shows quarter-end positions and arrives up to 45 days later.
| Fund | Of its portfolio | Value | Change | Quarter |
|---|---|---|---|---|
| Maverick Capital | 0.01% | $693K | New | Q2 2026 |
| Ray DalioBridgewater Associates | 0.00% | $625K | New | Q2 2026 |
